Anaemia and red blood cell transfusion in the critically ill patient

被引:38
作者
McLellan, SA [1 ]
McClelland, DBL
Walsh, TS
机构
[1] Univ Edinburgh, Royal Infirm, Dept Anaesthet Crit Care & Paine Med, Edinburgh EH3 9YW, Midlothian, Scotland
[2] Univ Edinburgh, Royal Infirm, Scottish Natl Blood Transfus Serv, Edinburgh EH3 9YW, Midlothian, Scotland
关键词
anaemia; blood transfusion; critical illness; transfusion thresholds; transfusion triggers;
D O I
10.1016/S0268-960X(03)00018-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Anaemia is a common finding in critically ill patients. There are often multiple causes. Obvious causes include surgical bleeding and gastrointestinal haemorrhage but many patients have no overt bleeding episodes. Phlebotomy can be a significant source of blood loss. In addition, critically ill patients have impaired erythropoiesis as a consequence of blunted erythropoietin production and direct inhibitory effects of inflammatory cytokines. The ability of a patient to tolerate anaemia depends on their clinical condition and the presence of any significant co-morbidity; maintenance of circulating volume is of paramount importance. There is no universal transfusion trigger. Current guidelines for critically ill and perioperative patients advise that at Hb values <70g/L red blood cell transfusion is strongly indicated and at Hb values >100 g/L transfusion is unjustified. For patients with Hb values in the range 70 to 100 g/L the transfusion trigger should be based on clinical indicators. Most stable critically ill patients can probably be managed with a Hb concentration between 70 and 90 g/L. Uncertainties exist concerning the most appropriate Hb concentration for patients with significant cardio-respiratory disease. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:195 / 208
页数:14
相关论文
共 131 条
[81]  
MEANS RT, 1992, BLOOD, V80, P1639
[82]   USE OF ERYTHROPOIETIN TO INCREASE THE VOLUME OF AUTOLOGOUS BLOOD DONATED BY ORTHOPEDIC PATIENTS [J].
MERCURIALI, F ;
ZANELLA, A ;
BAROSI, G ;
INGHILLERI, G ;
BIFFI, E ;
VINCI, A ;
COLOTTI, MT .
TRANSFUSION, 1993, 33 (01) :55-60
[83]  
MIRHASHEMI S, 1987, INT J MICROCIRC, V6, P359
[84]   Significance of hyperlactatemia without acidosis during hypermetabolic stress [J].
Mizock, BA .
CRITICAL CARE MEDICINE, 1997, 25 (11) :1780-1781
[85]   Reduced red cell 2,3-diphosphoglycerate concentrations in critical illness without decreased in vivo P50 [J].
Morgan, TJ ;
Koch, D ;
Morris, D ;
Clague, A ;
Purdie, DM .
ANAESTHESIA AND INTENSIVE CARE, 2001, 29 (05) :479-483
[86]   EFFECT OF A REDUCTION IN BLOOD-VISCOSITY ON MAXIMAL MYOCARDIAL OXYGEN DELIVERY DISTAL TO A MODERATE CORONARY STENOSIS [J].
MOST, AS ;
RUOCCO, NA ;
GEWIRTZ, H .
CIRCULATION, 1986, 74 (05) :1085-1092
[87]   RELATIONSHIP BETWEEN POSTOPERATIVE ANEMIA AND CARDIAC MORBIDITY IN HIGH-RISK VASCULAR PATIENTS IN THE INTENSIVE-CARE UNIT [J].
NELSON, AH ;
FLEISHER, LA ;
ROSENBAUM, SH .
CRITICAL CARE MEDICINE, 1993, 21 (06) :860-866
[88]   Arterial blood sampling practices in intensive care units in England and Wales [J].
O'Hare, D ;
Chilvers, RJ .
ANAESTHESIA, 2001, 56 (06) :568-571
[89]  
OPELZ G, 1973, TRANSPLANT P, V5, P253
[90]   Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients [J].
Opelz, G ;
Vanrenterghem, Y ;
Kirste, G ;
Gray, DWR ;
Horsburgh, T ;
Lachance, JG ;
Largiader, F ;
Lange, H ;
VujaklijaStipanovic, K ;
AlvarezGrande, J ;
Schott, W ;
Hoyer, J ;
Schnuelle, P ;
Descoeudres, C ;
Ruder, H ;
Wujciak, T ;
Schwarz, V .
TRANSPLANTATION, 1997, 63 (07) :964-967